HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 192 filers reported holding HORIZON PHARMA PLC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,898,000 | +206.7% | 109,700 | +126.6% | 0.17% | +171.9% |
Q4 2018 | $945,000 | +0.5% | 48,406 | +0.8% | 0.06% | +60.0% |
Q3 2018 | $940,000 | +18.2% | 48,000 | 0.0% | 0.04% | +8.1% |
Q2 2018 | $795,000 | +47.2% | 48,000 | +26.3% | 0.04% | +37.0% |
Q1 2018 | $540,000 | -49.8% | 38,000 | -48.4% | 0.03% | -48.1% |
Q4 2017 | $1,076,000 | +15.2% | 73,687 | 0.0% | 0.05% | +13.0% |
Q3 2017 | $934,000 | +67.4% | 73,687 | +56.5% | 0.05% | +70.4% |
Q2 2017 | $558,000 | -9.0% | 47,087 | +13.5% | 0.03% | -27.0% |
Q1 2017 | $613,000 | -56.4% | 41,487 | -52.3% | 0.04% | -51.9% |
Q4 2016 | $1,407,000 | +3.5% | 86,960 | +16.0% | 0.08% | +16.7% |
Q3 2016 | $1,360,000 | +144.6% | 74,960 | +121.8% | 0.07% | +78.4% |
Q2 2016 | $556,000 | +8.2% | 33,800 | +9.0% | 0.04% | +15.6% |
Q1 2016 | $514,000 | -74.4% | 31,000 | -66.5% | 0.03% | -73.1% |
Q4 2015 | $2,007,000 | +913.6% | 92,560 | +825.6% | 0.12% | +891.7% |
Q3 2015 | $198,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |